ArticleCureus2025

Postmarket Safety Surveillance of FDA-Cleared Prescription Digital Therapeutics Using the Manufacturer and User Facility Device Experience (MAUDE) Database: A Pharmacovigilance Study.

Shaheen E LakhanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.